跳至主要内容
临床试验/ITMCTR2000003127
ITMCTR2000003127招募中1 期

Retrospective study for the efficacy of ulinastatin combined with ''clear lung detoxification soup'' in the treatment of novel coronavirus pneumonia (COVID-19)

Wuhan Third Hospital0 个研究点开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • The confirmed patients with common type of new coronavirus pneumonia were selected, and the diagnostic criteria were shown in [diagnosis and treatment scheme 5.0 for pneumonia caused by new coronavirus infection].

排除标准

  • 1. Aged > 75 years old and < 18 years old;
  • 2. Patients who are contraindicated or allergic to this study drug (lung-clearing and detoxification decoction and ulinastatin for injection);
  • 3. Patients with previous tumor, severe liver disease, pulmonary fibrosis, tuberculosis, autoimmune diseases, and treatment with glucocorticoids and immunosuppressive agents;
  • 4. The diagnostic criteria for severe patients with novel coronavirus pneumonia were [novel coronavirus infection pneumonia treatment scheme 5.0].

研究者

发起方
Wuhan Third Hospital

相似试验